Google's disclosure of their new "Willow" quantum chip adds to the value of their "futuretech" franchise, which is growing in all the right places.

 

Alphabet Inc (GOOG)
$183.41 Up +$43.85(+31.42%)Year to date

Alphabet Inc. (GOOG), the parent company of Google, continues to demonstrate robust financial performance and significant advancements in technology, particularly in quantum computing, autonomous vehicles through Waymo, and artificial intelligence (AI).

Financial Performance

In the third quarter of 2024, Alphabet reported a 15% year-over-year increase in revenue, reaching $88.27 billion. Net income rose by 33.6% to $26.3 billion, surpassing Wall Street's expectations.

Associated Press

This growth was primarily driven by the strong performance of Google Services, including Search and YouTube, as well as a 35% increase in Google Cloud revenue, which amounted to $11.4 billion.

Reuters

Quantum Computing Advancements

On December 9, 2024, Google unveiled its new quantum computing chip, Willow, marking a significant breakthrough in the field. The Willow chip successfully solved a complex problem in five minutes—a task that would take classical computers longer than the age of the universe.

blog.google/technology/research/google-willow-quantum-chip/

Reuters

This advancement addresses major challenges in quantum computing, particularly in error correction, and brings Google closer to practical applications in medicine and artificial intelligence.

Waymo's Robotaxi Development and Growth

Waymo, Alphabet's autonomous vehicle subsidiary, has made substantial progress in expanding its robotaxi services. In 2023, Waymo launched its autonomous ride-hailing service in major cities, including San Francisco, Los Angeles, and Austin.

Fast Company

In October 2024, Waymo closed a $5.6 billion funding round led by Alphabet, aiming to further expand its services and technological capabilities.

Yahoo Finance

The company is also integrating advanced AI models, such as Google's Gemini, to enhance the performance and safety of its autonomous vehicles.

The Verge

AI Technology Advancements

Alphabet continues to invest heavily in AI across its product portfolio. The company is integrating large language models and vision-language models into various services, enhancing capabilities in areas like autonomous driving and cloud computing. These investments have contributed to the growth of Google Cloud, which reported a 35% revenue increase in the third quarter of 2024.

Reuters

Other Growth Projections

Alphabet's diverse portfolio includes ventures in healthcare through Verily, advancements in AI with DeepMind, and various "Other Bets" that position the company for future growth. The company's commitment to innovation and substantial investments in emerging technologies suggest a positive outlook for continued expansion and profitability.

In summary, Alphabet's strong financial performance, coupled with significant technological advancements in quantum computing, autonomous vehicles, and AI, underscores its position as a leader in the tech industry and indicates promising growth prospects moving forward.

Can two small caps become the kings of synthetic biology? Only time will tell!

 Both Twist Biosciences and Ginkgo Bioworks are prominent players 

in the field of  Synthetic biology, but they have different focuses and strengths.

Let’s take a closer look at each company: Twist Biosciences: Core Focus: Twist Biosciences specializes in high-quality synthetic DNA production using its Silicon Platform. They offer custom DNA synthesis services to researchers, biotech companies, and other organizations. Technology: Their Silicon Based DNA synthesis platform allows for efficient and precise DNA manufacturing. Applications: Twist’s DNA products are used in various applications, including Gene Editing, vaccine development, Drug discovery, and more. Collaboration with Ginkgo: Twist has a collaboration with Ginkgo Bioworks, which includes a four-year supply agreement. Ginkgo purchases products from Twist, allowing them to test proteins and develop diverse solutions across multiple industries. Recent Deal: In 2022, Twist agreed to supply at least 100 million base pairs of synthetic DNA to Ginkgo over a one-year period for engineering prototype organisms. Ginkgo Bioworks: Core Focus: Ginkgo is a horizontal platform for cell programming. They aim to make programming cells as easy as programming computers. Technology: Ginkgo’s platform enables biotechnology applications across various markets, including food, agriculture, industrial chemicals, and pharmaceuticals. Applications: Ginkgo focuses on organism design and engineering, optimization, and other synthetic biology services. Collaboration with Twist: Ginkgo collaborates with Twist to secure high volumes of DNA. They have ordered approximately one billion base pairs of synthetic DNA from Twist over the past four years for various programs. Expansion Plans: Ginkgo’s collaboration with Twist aims to fuel their expansion plans in the synthetic biology field. In summary, both companies contribute significantly to the synthetic biology ecosystem, but their expertise lies in different areas.

Twist excels in DNA synthesis, while Ginkgo focuses on cell programming and organism engineering.

The collaboration between these two organizations demonstrates their commitment to advancing the field of synthetic biology.

Foot notes:

Most recently Googles "Deep Mind" Ai has been used in combination with Synbio, cell programming and gene editing, to further the advancement in cooperation with a number of companies.

With the deep, data set of Alphabet, combined with Deep Mind's cutting edge Ai, and the massive data bank that is the human DNA, medicine and medical disciplines will benefit immensely from what is coming! And, so will human kind!